Homepage About Genepoint Product Center Careers

Outstanding Provider of

Low-temperature Storage Solutions

for Biological Samples

Genepoint is committed to providing innovative, proprietary, automated, intelligent, and whole-process solutions for the low-temperature preservation of biological samples. Following our mission of "inspire life exploration" and with the vision of "becoming a respected company in the field of life sciences", we continuously break through the boundaries of technological innovation in low-temperature storage and management of samples, and accelerate the practice and exploration of life sciences and biopharmaceuticals.

Corporate History

2015 to 2017

- Establishment of founding team, establishment of Genepoint in Shanghai and Chengdu

- The first generation Hatch engineering machine makes its debut

2018 to 2019

- Hatch Lite was launched, and won the ISBER 2019 Outstanding New Product Award

- Awarded bids for numerous projects, including the Singapore Academy of Sciences, the National Gene Bank, and the Guangzhou Women and Children's Medical Center

2020 to 2021

- Kiosk-80 ℃ fully automatic sample repository system was launched

- Awarded benchmark projects such as the Fudan University Shanghai Cancer Center, Peking Union Medical College Hospital, and others

- Selected as a Specialized and Sophisticated Enterprise in Shanghai

2022 to 2023

- Comprehensively roll out of corporate industrialization strategy; construction begins on Suzhou factory

- Launch of the Sinfo consumables series

Corporate History

2015 to 2017

- Establishment of founding team, establishment of Genepoint in Shanghai and Chengdu

- The first generation Hatch engineering machine makes its debut

- Angel investment obtained from Bangming Capital

2018 to 2019

- Hatch Lite was launched, and won the ISBER 2019 Outstanding New Product Award

- Awarded bids for numerous projects, including the Singapore Academy of Sciences, the National Gene Bank, and the Guangzhou Women and Children's Medical Center

- Obtained Series A financing from Zhongwei, and Series B financing from Chengtan

2020 to 2021

- Kiosk-80 ℃ fully automatic sample repository system was launched

- Awarded benchmark projects such as the Fudan University Shanghai Cancer Center, Peking Union Medical College Hospital, and others

- Selected as a Specialized and Sophisticated Enterprise in Shanghai

- Obtained Series C financing from Northern Light

2022 to 2023

- Comprehensively roll out of corporate industrialization strategy; construction begins on Suzhou factory

- Launch of the Sinfo consumables series

- Obtained Series D financing from Zhouling Capital and Series D+ financing from Guofang Capital

Adhering to independent research and development, letting innovation serve value

Independent research and development, breaking through the boundaries of technological innovation